Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008
- PMID: 26215544
- DOI: 10.1111/ijcp.12709
Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008
Abstract
Objective: The objective of this study was to investigate rural/urban and socio-demographic disparities in lower urinary tract symptoms and benign prostatic hyperplasia (LUTS/BPH) in a nationally representative population of men.
Methods: Data on men age ≥40 years (N = 4,492) in the 2001-2008 National Health and Nutrition Examination Surveys were analysed. Self-report of physician-diagnosed enlarged prostate and/or BPH medication use defined recognised LUTS/BPH. Urinary symptoms without BPH diagnosis/medications defined unrecognised LUTS/BPH. Rural-Urban Commuting Area Codes assessed urbanisation. Unadjusted and multivariable associations (odds ratios (OR)) between LUTS/BPH and covariates were calculated using logistic regression.
Results: Recognised and unrecognised LUTS/BPH weighted-prevalence estimates were 16.5% and 9.6%. There were no significant associations between LUTS/BPH and rural/urban status. Significant predisposing factors for increased adjusted odds of recognised and unrecognised LUTS/BPH included age, hypertension (OR=1.4;1.4), analgesic use (OR=1.4;1.4) and PSA level >4 ng/mL (OR=2.3;1.9) when adjusted for rural/urban status, race, education, income, alcohol, health insurance, health care and proton pump inhibitor (PPI) use (all p ≤ 0.1). Restricting to urban men only (N = 3,371), healthcare use (≥4visits/year) and PPI's increased adjusted odds of recognised LUTS/BPH (OR=2.0;1.6); no health insurance and <high school education decreased odds (OR=0.5;0.6) after adjusting for variables listed above, antidepressant and calcium channel blocker use (p ≤ 0.1). Also among urban men, adjusted odds of unrecognised LUTS/BPH increased for blacks (OR=1.9), Hispanic/Other (OR=1.9) and income<$34,999 (OR=1.6). Among rural men only (N = 1,121), adjusted odds of recognised and unrecognised LUTS/BPH increased for age, hypertension (OR=1.9;1.7) and analgesic use (OR=2.0;1.5) when adjusting for race, CRP, antidepressant and dyslipidaemic use (p ≤ 0.1).
Conclusion: Rural/urban status was not associated with significantly increased adjusted odds of either recognised or unrecognised LUTS/BPH.
© 2015 John Wiley & Sons Ltd.
Similar articles
-
Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.BMJ Open. 2019 Jun 19;9(6):e022792. doi: 10.1136/bmjopen-2018-022792. BMJ Open. 2019. PMID: 31221864 Free PMC article.
-
Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.BJU Int. 2016 Jan;117(1):145-54. doi: 10.1111/bju.13050. Epub 2015 Apr 23. BJU Int. 2016. PMID: 25601300 Free PMC article.
-
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.BJU Int. 2015 Apr;115(4):508-19. doi: 10.1111/bju.12745. Epub 2014 Oct 16. BJU Int. 2015. PMID: 24656222 Review.
-
The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.Urol Clin North Am. 2016 Aug;43(3):289-97. doi: 10.1016/j.ucl.2016.04.001. Urol Clin North Am. 2016. PMID: 27476122 Review.
-
Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.Prostate. 2019 Feb;79(3):312-319. doi: 10.1002/pros.23737. Epub 2018 Nov 18. Prostate. 2019. PMID: 30450670
Cited by
-
Role of α1-blockers in the current management of hypertension.J Clin Hypertens (Greenwich). 2022 Sep;24(9):1180-1186. doi: 10.1111/jch.14556. J Clin Hypertens (Greenwich). 2022. PMID: 36196467 Free PMC article. Review.
-
Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019.Am J Mens Health. 2021 Jul-Aug;15(4):15579883211036786. doi: 10.1177/15579883211036786. Am J Mens Health. 2021. PMID: 34330182 Free PMC article.
-
Exploring the association between caffeine intake and benign prostatic hyperplasia: results from the NHANES 2005-2008.Front Nutr. 2025 Jan 13;11:1511607. doi: 10.3389/fnut.2024.1511607. eCollection 2024. Front Nutr. 2025. PMID: 39872138 Free PMC article.
-
The Assessment of Patient-Reported Outcomes in the Medical Management of Patients With Benign Prostatic Hyperplasia.Cureus. 2024 Aug 16;16(8):e67027. doi: 10.7759/cureus.67027. eCollection 2024 Aug. Cureus. 2024. PMID: 39280479 Free PMC article.
-
A community-based study on lower urinary tract symptoms in Malaysian males aged 40 years and above.Sci Rep. 2022 Feb 11;12(1):2345. doi: 10.1038/s41598-022-05890-9. Sci Rep. 2022. PMID: 35149733 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous